Target- |
MechanismMagnetic resonance imaging enhancers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Jan 1993 |
100 Clinical Results associated with GE Healthcare Pharma Ltd.
0 Patents (Medical) associated with GE Healthcare Pharma Ltd.
100 Deals associated with GE Healthcare Pharma Ltd.
100 Translational Medicine associated with GE Healthcare Pharma Ltd.